Optimized Post-Vaccination Strategies and Preventative Measures for SARS-CoV-2

INTRODUCTION: Since March of 2020, over 210 million SARS-CoV-2 cases have been reported and roughly five billion doses of a SARS-CoV-2 vaccine have been delivered. The rise of the more infectious delta variant has recently indicated the value of reinstating previously relaxed non-pharmacological and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettit, Rowland, Peng, Bo, Yu, Patrick, Matos, Peter G., Greninger, Alexander L., McCashin, Julie, Amos, Christopher Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475973/
https://www.ncbi.nlm.nih.gov/pubmed/34580677
http://dx.doi.org/10.1101/2021.09.17.21263723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475973/
https://www.ncbi.nlm.nih.gov/pubmed/34580677
http://dx.doi.org/10.1101/2021.09.17.21263723

Ejemplares similares